↓ Skip to main content

Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab

Overview of attention for article published in Arthritis Research & Therapy, October 2015
Altmetric Badge

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
88 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab
Published in
Arthritis Research & Therapy, October 2015
DOI 10.1186/s13075-015-0799-7
Pubmed ID
Authors

Shintaro Hirata, Anthony Marotta, Yuan Gui, Kentaro Hanami, Yoshiya Tanaka

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 1%
United Kingdom 1 1%
Spain 1 1%
Germany 1 1%
Unknown 84 95%

Demographic breakdown

Readers by professional status Count As %
Other 16 18%
Researcher 13 15%
Student > Master 12 14%
Unspecified 9 10%
Student > Ph. D. Student 7 8%
Other 12 14%
Unknown 19 22%
Readers by discipline Count As %
Medicine and Dentistry 31 35%
Biochemistry, Genetics and Molecular Biology 9 10%
Unspecified 9 10%
Agricultural and Biological Sciences 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Other 11 13%
Unknown 19 22%